About the Company
Shattuck-St. Mary's (also known as Shattuck-St. Mary's School, Shattuck, or simply SSM) is a coeducational Episcopal-affiliated boarding school in the city of Faribault in the U.S. State of Minnesota. Established in 1858 as an Episcopal mission school and seminary, within a decade the school grew to include Shattuck Military Academy, St. Mary's Hall for girls and later (in 1901) St. James School for younger boys. In 1974, the three schools dropped all military programs and combined as Shattuck-St. Mary's. It is now known for its Centers of Excellence programs in engineering, bioscience, pre-conservatory music, and vocal performance, as well as hockey, soccer, figure skating, and golf. Approximately 70% of its students are boarders.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $STTK News
STTK Shattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company’s lead product candidate ...
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
Significantly high institutional ownership implies Shattuck Labs' stock price is sensitive to their trading actions 53% of the business is held by the top 7 shareholders 13% of Shattuck Labs is held ...
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small ...
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
AUSTIN, TX and DURHAM, NC, March 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional ...
Strong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadership
Gil Blum, an analyst from Needham, maintained the Buy rating on Shattuck Labs (STTK – Research Report). The associated price target ...
Shattuck Labs Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion ...
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the ...
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
AUSTIN, TX and DURHAM, NC, March 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion ...
Shattuck Labs Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...